In-vitro lab research use only
The absolute bioavailability following intramuscular injection was found to be approximately 1419% in rats and 4551% in beagle dogs, indicating variable absorption depending on the species and administration route
This includes consumer related information and updates on the regulation of products and substances that may cause an adverse health event and/or positive anti-doping test.
downregulation of destructive MMPs (MMP-1, MMP-3) Antioxidant systems: Increased expression of glutathione reductase, thioredoxin reductase, and superoxide dismutase isoformseffects documented in Pickarts 2015 study (PMID: 28386432) Angiogenesis control: Modulation of VEGF and angiopoietin pathways, explaining observed wound-healing acceleration in diabetic ulcer models Neuronal protection: Upregulation of neuronal survival factors and downregulation of pro-apoptotic proteins in hippocampal neuron culturesa neuroprotective dimension entirely absent from UK marketing materials This gene-regulatory breadth means clinical applications extend far beyond dermal cosmesis
When stratified by administration route, the average percentage reductions were: Intramuscular (IM): 48.3% Sublingual: 30.7% Oral: 30.3% These results suggest that IM administration leads the most pronounced homocysteine reduction, however, sublingual and oral routes also demonstrate clinically relevant effects